BLOCK DRUG CO INC

Block Drug Co Inc still markets a legacy suite of personal-care and over-the-counter health products—oral hygiene, first-aid, and seasonal cold remedies—that long served wholesalers, pharmacy chains, and value-minded consumers seeking affordable basics. Rooted in SIC 2834, the company operates within the broader pharmaceuticals and allied products landscape, so its supply chain, product formulation, and labeling processes remain entangled with FDA oversight and evolving consumer-health standards; any shifts in ingredient approvals, shelf-life testing, or retail consolidation could ripple through its revenue base. While the latest filing is unknown, investors should note that the company’s history of asset transitions means that balance-sheet transparency, compliance with regulatory reporting deadlines, and inventory management are material risks that could affect stakeholder confidence. CIK 12654 captures the firm’s SEC identity, and those tracking how it navigates product innovation, compliance burdens, and channel partnerships can view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025